You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-UBE2I / UBC9 antibody (ab30505)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-UBE2I / UBC9 antibody
See all UBE2I / UBC9 products (6) ...

Description

Rabbit polyclonal to UBE2I / UBC9

Tested applications

WB, ICC/IFmore details

Cross reactivity

Reacts with

Mouse, Rat, Human

Predicted to work with

Chicken, Xenopus laevis, Fruit fly (Drosophila melanogaster), Zebrafish

Immunogen

Synthetic peptide conjugated to KLH derived from within residues 50 - 150 of Human UBE2I / UBC9.

(Peptide available as ab30700.)

Positive control

This antibody gave a positive result in the following whole cell lysates: HeLa (Human epithelial carcinoma cell line) Jurkat (Human T cell lymphoblast-like cell line) A431 (Human epithelial carcinoma cell line) NIH 3T3 (Mouse embryonic fibroblast cell line) MEF1 (Mouse embryonic fibroblast cell line) PC12 (Rat adrenal pheochromocytoma cell line) and tissue lysates: Testis (Mouse) Tissue Lysate - normal tissue Ovary (Mouse) Tissue Lysate - normal tissue

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.02% Sodium Azide
Constituents: 1% BSA, PBS, pH 7.4

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • Western blot - UBE2I / UBC9 antibody (ab30505)Western blot - UBE2I / UBC9 antibody (ab30505) image (enlarge)

  • Western blot - UBE2I / UBC9 antibody (ab30505)Western blot - UBE2I / UBC9 antibody (ab30505) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - UBE2I / UBC9 antibody (ab30505)Immunocytochemistry/ Immunofluorescence - UBE2I / UBC9 antibody (ab30505) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab30505 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Accepts the ubiquitin-like proteins SUMO1, SUMO2, SUMO3 and SUMO4 from the UBLE1A-UBLE1B E1 complex and catalyzes their covalent attachment to other proteins with the help of an E3 ligase such as RANBP2 or CBX4. Necessary for sumoylation of FOXL2 and KAT5. Essential for nuclear architecture and chromosome segregation.

Tissue specificity

Expressed in heart, skeletal muscle, pancreas, kidney, liver, lung, placenta and brain. Also expressed in testis and thymus.

Pathway

Protein modification; protein sumoylation.

Sequence similarities

Belongs to the ubiquitin-conjugating enzyme family.

Cellular localization

Nucleus. Cytoplasm. Mainly nuclear. In spermatocytes, localizes in synaptonemal complexes. Recruited by BCL11A into the nuclear body.

Target information above from: UniProt accessionP63279 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • p18 antibody
  • SUMO conjugating enzyme UBC9 antibody
  • SUMO-1 conjugating enzyme antibody
  • SUMO-1-protein ligase antibody
  • SUMO-conjugating enzyme UBC9 antibody
  • SUMO-protein ligase antibody
  • SUMO1 protein ligase antibody
  • UBC9 antibody
  • UBC9_HUMAN antibody
  • UBCE9 antibody
  • Ube2i antibody
  • Ubiquitin carrier protein 9 antibody
  • Ubiquitin carrier protein antibody
  • Ubiquitin carrier protein I antibody
  • Ubiquitin conjugating enzyme 9 antibody
  • Ubiquitin-conjugating enzyme E2 I antibody
  • Ubiquitin-protein ligase I antibody
see all

Anti-UBE2I / UBC9 antibody images:

  Western blot - UBE2I / UBC9 antibody (ab30505)

Western blot - UBE2I / UBC9 antibody (ab30505)

All lanes : Anti-UBE2I / UBC9 antibody (ab30505) at 1 µg/ml

Lane 1 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate
Lane 2 : Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate (ab7899)
Lane 3 : A431 (Human epithelial carcinoma cell line) Whole Cell Lysate (ab7909)

Lysates/proteins at 20 µg per lane.

Secondary
IR Dye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/15000 dilution

Performed under reducing conditions.

Predicted band size : 18 kDa
Observed band size : 18 kDa

  Western blot - UBE2I / UBC9 antibody (ab30505)

Western blot - UBE2I / UBC9 antibody (ab30505)

All lanes : Anti-UBE2I / UBC9 antibody (ab30505) at 1 µg/ml

Lane 1 : NIH 3T3 (Mouse embryonic fibroblast cell line) Whole Cell Lysate (ab7179)
Lane 2 : MEF1 (Mouse embryonic fibroblast cell line) Whole Cell Lysate
Lane 3 : Testis (Mouse) Tissue Lysate - normal tissue
Lane 4 : Ovary (Mouse) Tissue Lysate - normal tissue
Lane 5 : PC12 (Rat adrenal pheochromocytoma cell line) Whole Cell Lysate

Lysates/proteins at 10 µg per lane.

Secondary
IRDye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/10000 dilution

Performed under reducing conditions.

Predicted band size : 18 kDa
Observed band size : 18 kDa

  Immunocytochemistry/ Immunofluorescence - UBE2I / UBC9 antibody (ab30505)

Immunocytochemistry/ Immunofluorescence - UBE2I / UBC9 antibody (ab30505)

ICC/IF image of ab30505 stained human HeLa cells. The cells were PFA fixed (10 min), permabilised in TBS-T (20 min) and incubated with the antibody (ab30505, 5µg/ml) for 1h at room temperature. 1%BSA / 10% normal goat serum / 0.3M glycine was used to quench autofluorescence and block non-specific protein-protein interactions. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red). DAPI was used to stain the cell nuclei (blue).

References for Anti-UBE2I / UBC9 antibody (ab30505)

This product has been referenced in:

  • Boutell Cet al. A Viral Ubiquitin Ligase Has Substrate Preferential SUMO Targeted Ubiquitin Ligase Activity that Counteracts Intrinsic Antiviral Defence. PLoS Pathog 7:e1002245 (2011). WB; Human.Read more (PubMed: 21949651) »

See 1 publication for this product

Publishing research using ab30505? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"